Crossmark

Protection from noise-induced cochlear synaptopathy by virally mediated overexpression of NT3

Crossref DOI link: https://doi.org/10.1038/s41598-019-51724-6

Published Online: 2019-10-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hashimoto, Ken

Hickman, Tyler T. https://orcid.org/0000-0003-2623-3251
Suzuki, Jun https://orcid.org/0000-0002-9164-6389
Ji, Lingchao

Kohrman, David C.

Corfas, Gabriel https://orcid.org/0000-0001-5412-9473
Liberman, M. Charles
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (R01 DC 000188, R01 DC 000188, R01 DC 000188, R01 DC004820, R01 DC004820, R01 DC 000188)

U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders

Tom and Helene Lauer

U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders

U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders

U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders

U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders
License Information

Text and Data Mining valid from 2019-10-25

Version of Record valid from 2019-10-25
More Information

Article History

Received: 29 July 2019

Accepted: 26 September 2019

First Online: 25 October 2019

Competing interests

: G.C. and M.C.L. are scientific founders of Decibel Therapeutics, and have an equity interest in and have received compensation for consulting, but the company was not involved in this study.

Document is current

Any future updates will be listed below